STOCK TITAN

National Healthcare Properties Announces Final Results of its Series A and Series B Preferred Stock Self Tender Offers

(Moderate)
(Neutral)
Tags

National Healthcare Properties (Nasdaq:NHP) announced final results of its concurrent self tender offers for its 7.375% Series A and 7.125% Series B preferred stock.

The company accepted 556,454 Series A and 566,229 Series B shares at $22.50 per share, for a total of about $25.3 million.

Loading...
Loading translation...

Positive

  • Repurchased 556,454 Series A preferred shares, about 14.5% of that series
  • Repurchased 566,229 Series B preferred shares, about 16.6% of that series
  • Total preferred stock repurchase of approximately $25.3 million in cash
  • Tender price of $22.50 per share provided liquidity to preferred holders

Negative

  • Cash outflow of approximately $25.3 million, excluding related fees and expenses
  • Company is restricted from further Series A or B repurchases for at least ten business days

News Market Reaction – NHPAP

+0.11%
+0.11% Session close to close

In the Jun 23 session, NHPAP gained 0.11%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement confirms completion of preferred self tenders at $22.50, retiring about 14.5% of S...
Analysis

This announcement confirms completion of preferred self tenders at $22.50, retiring about 14.5% of Series A and 16.6% of Series B. It follows prior tender updates; future repurchases depend on cash, financing and other strategic uses.

Key Figures

Tender offer cap: $100 million Purchase price: $22.50 per share Series A shares purchased: 556,454 shares +5 more
8 metrics
Tender offer cap $100 million Maximum aggregate cash purchase price for Series A and B tenders
Purchase price $22.50 per share Cash consideration per Series A and Series B preferred share
Series A shares purchased 556,454 shares Series A preferred properly tendered and accepted
Series B shares purchased 566,229 shares Series B preferred properly tendered and accepted
Aggregate purchase price $25.3 million Total cash paid for accepted Series A and B shares, excl. fees
Series A retired 14.5% Portion of issued and outstanding Series A shares repurchased
Series B retired 16.6% Portion of issued and outstanding Series B shares repurchased
Repurchase blackout 10 business days Minimum wait before additional Series A or B repurchases under law

Historical Context

5 past events · Latest: Jun 17 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 17 Tender results update Positive +0.7% Preliminary results of preferred stock self tender offers and expected purchase amounts.
Jun 01 Business update Positive +0.0% SHOP acquisition pipeline, index inclusion and investor presentation details.
May 18 Tender launch Positive +3.0% Launch of cash tender offers for Series A and B preferred shares.
May 13 Q1 2026 earnings Neutral +2.5% Mixed quarter with net loss but FFO, SHOP growth and capital markets activity.
May 04 Portfolio sale Positive +4.4% Agreement to sell outpatient facilities to reweight toward SHOP and de-lever.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news, especially on tenders, portfolio sales and financing, has generally coincided with modest positive price reactions.

Key Terms

self tender offers, cumulative redeemable perpetual preferred stock, par value, withholding taxes
4 terms
self tender offers financial
"today announced the final results of its concurrent but separate offers to purchase"
A self tender offer is when a company offers to buy back its own shares directly from shareholders at a set price for a limited time, similar to a store offering to repurchase some of its gift cards. Investors care because it reduces the number of shares available, can put upward pressure on the stock price, changes each remaining shareholder’s ownership stake, and signals how management values the business compared with the market.
cumulative redeemable perpetual preferred stock financial
"its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value"
A cumulative redeemable perpetual preferred stock is a type of ownership share that pays fixed dividends forever unless the company stops them, and any missed dividends accumulate and must be paid later. It can be redeemed (bought back) by the issuer at specified times or prices, so it behaves partly like a long-term loan; investors care because it sits ahead of common shares for payments and can affect a company’s cash needs and perceived credit risk.
par value financial
"7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
withholding taxes financial
"for a purchase price of $22.50 per share in cash ... less any applicable withholding taxes"
Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP / NHPAP / NHPBP) (the “Company”), a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States, today announced the final results of its concurrent but separate offers to purchase up to a maximum aggregate purchase price in cash of $100 million of (i) its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the “Series A Shares”), and (ii) its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the “Series B Shares,” and together with the Series A Shares, the “Shares”), in each case for a purchase price of $22.50 per share in cash (collectively, the “Offers”), each less any applicable withholding taxes and without interest. The Offers each expired at 5:00 p.m., New York City time, on June 16, 2026 (the “Expiration Date”).

Based on the final count by Computershare Inc. (“Computershare”), the depositary for the Offers, 556,454 Series A Shares and 566,229 Series B Shares were properly tendered and not properly withdrawn as of the expiration of the Offers. In accordance with the terms and conditions of the Offers, the Company accepted for purchase all such 556,454 Series A Shares and 566,229 Series B Shares for an aggregate purchase price of approximately $25.3 million, excluding fees and expenses relating to the Offers. The shares purchased represent approximately 14.5% of the Company’s issued and outstanding Series A Shares and 16.6% of the Company’s issued and outstanding Series B Shares as of June 17, 2026. The Company will promptly pay for the Shares accepted for purchase in cash, less any applicable withholding taxes and without interest.

The Company may purchase additional Series A Shares or Series B Shares in the future, including, without limitation, under its publicly announced preferred stock repurchase program. The amount and timing of any such purchases will depend on a number of factors, including the availability of cash and/or financing on acceptable terms, the amount and timing of dividend payments, if any, and periods in which the Company is restricted from repurchasing Series A Shares or Series B Shares, as well as any decision to use cash for other strategic objectives. Under applicable law, the Company may not repurchase any additional Series A Shares or Series B Shares until at least ten business days after the expiration of the Offers, subject to certain limited exceptions provided under applicable securities laws.

For all questions relating to the Offers, please call the information agent, Georgeson LLC, toll-free at (866) 831-9374.

About National Healthcare Properties

National Healthcare Properties, Inc. (Nasdaq: NHP) is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States. Additional information about the Company can be found on its website at nhpreit.com.

Investor & Media Contact

Email: ir@nhpreit.com

Cautionary Statement Regarding Forward-Looking Statements

This press release may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements include the Company’s ability to complete the Offers on the terms and timing described herein, or at all. There can be no assurance that the Company will complete the Offers. Forward-looking statements generally can be identified by the use of terminology such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “should,” “predict,” “project,” “potential,” “continue” or the negatives of these terms or variations of them or similar expressions. Risks and uncertainties, the occurrence of which could adversely affect the Company’s business and cause actual results to differ materially from those expressed or implied in the forward-looking statements, include, but are not limited to, the following: the trading prices of the Series A Shares and Series B Shares; changes in economic cycles generally and in the real estate and healthcare markets specifically; the success of the Company’s growth strategy, including its ability to successfully identify, complete and integrate new acquisitions; the Company’s ability to complete acquisitions or dispositions on the terms and timing the Company expects, or at all; changes to inflation and interest rates; competition in the real estate and healthcare markets; the Company’s ability to retain certain key personnel; legislative and regulatory changes in the healthcare and real estate industries; reductions or changes in reimbursement from third-party payors, including Medicare and Medicaid; discovery of previously undetected environmentally hazardous conditions; the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; system failures, cyber incidents or deficiencies in the Company’s cybersecurity systems; the availability of capital on favorable terms, or at all; the Company’s ability to remain qualified as a real estate investment trust for U.S. federal income tax purposes; and other risks and uncertainties described in the section titled Risk Factors of the Company’s most recent Annual Report on Form 10-K and all other filings with the Securities and Exchange Commission. Finally, the Company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.


FAQ

What were the final results of National Healthcare Properties' June 2026 preferred stock tender offers (Nasdaq:NHP)?

National Healthcare Properties accepted 556,454 Series A and 566,229 Series B preferred shares. According to National Healthcare Properties, these purchases total about $25.3 million in cash at $22.50 per share, excluding fees, taxes and accrued interest.

How many Series A preferred shares did National Healthcare Properties (NHPAP) buy in its 2026 self tender offer?

National Healthcare Properties purchased 556,454 Series A preferred shares in the offer. According to National Healthcare Properties, this represents approximately 14.5% of its issued and outstanding Series A preferred shares as of June 17, 2026.

How many Series B preferred shares did National Healthcare Properties (NHPBP) repurchase in June 2026?

National Healthcare Properties repurchased 566,229 Series B preferred shares. According to National Healthcare Properties, these bought shares equal about 16.6% of its issued and outstanding Series B preferred stock as of June 17, 2026.

What was the purchase price in National Healthcare Properties' Series A and Series B preferred stock tender (NHP)?

The company paid $22.50 per share in cash for both series. According to National Healthcare Properties, this price applied to all accepted Series A and Series B shares, less any applicable withholding taxes and without interest.

When did National Healthcare Properties' concurrent preferred stock tender offers expire in 2026?

The tender offers expired at 5:00 p.m. New York City time on June 16, 2026. According to National Healthcare Properties, only shares properly tendered and not withdrawn by that expiration time were accepted for purchase.

Can National Healthcare Properties (NHP) repurchase more Series A or B preferred shares after the June 2026 tender?

The company may buy additional Series A or B preferred shares in the future. According to National Healthcare Properties, it cannot repurchase more for at least ten business days after expiration, and any future purchases depend on cash, financing and other factors.

What is the maximum cash amount National Healthcare Properties had authorized for its June 2026 preferred stock tender offers?

The company offered to purchase up to a total of $100 million of its preferred shares. According to National Healthcare Properties, the final accepted tenders for Series A and Series B combined resulted in a cash outlay of about $25.3 million, excluding fees and expenses.